Oral Anticoagulants: Implications for Patient Management - N1718


About Course #N1718

Release Date: August 25, 2016

Expiration Date: August 31, 2019

Oral anticoagulants are indicated for the management of thrombotic conditions, namely, in the prevention of stroke and systemic embolization and in the treatment of venous thromboembolism. Within the past 6 years, the landscape of managing these conditions in the United States has changed dramatically. The FDA has approved four oral anticoagulants representing alternatives to the gold standard oral anticoagulant warfarin that had been the only oral option for decades.

The focus of this course is on the newest oral anticoagulant drug therapies, their indications, and data supporting their use in clinical practice. This course is designed for advanced practice nursing prescribers who are involved in the decision making for oral anticoagulant selection; or who take care of patients who have already been prescribed oral anticoagulants. The purpose of this course is to increase advanced nursing prescribers' knowledge of oral anticoagulants to identify patients in whom therapy is indicated, to assist in selecting the most appropriate option, and to assist in appropriate monitoring and counseling the patient.

This course is an extract of, and should not be taken in conjunction with course #N1752 - Anticoagulant, Antiplatelet, and Thrombolytic Therapies: Implications for Advanced Practice Nursing.

Orthopedic Nurses - ONCB has approved this course for 1.5 Category A contact hours and 1.5 Category B contact hours toward recertification

About the Author(s)

Diana M. Sobieraj, PharmD, BCPS, earned her Doctor of Pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/The University of Connecticut School of Pharmacy. After her training, Dr. Sobieraj joined the faculty at UCONN School of Pharmacy, where she has worked for the past 8 years. Currently, Dr. Sobieraj is an Assistant Professor in the Department of Pharmacy Practice in the tenure track. Her scholarly interests focus on comparative effectiveness and health outcomes research of anticoagulants and the treatment and prevention of thrombosis. Dr. Sobieraj has more than 40 publications in the peer-reviewed literature, including journals such as Annals of Internal Medicine, Journal of the American Geriatrics Society, International Journal of Cardiology, and Thrombosis Research. Dr. Sobieraj is a member of the American College of Clinical Pharmacy, the current Secretary/Treasurer of the American College of Clinical Pharmacy Health Outcomes PRN, and a member of the Community Advisory Panel of the American College of Clinical Pharmacy Practice-Based Research Network.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 23.33ms
  • bvseo-msg: HTTP status code of 404 was returned;